Prognostic value of choline and creatine in WHO grade II gliomas
- 4 June 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neuroradiology
- Vol. 50 (9), 759-767
- https://doi.org/10.1007/s00234-008-0409-3
Abstract
Introduction The purpose of this study was to evaluate whether proton magnetic resonance spectroscopy (1H-MRS) predicts survival time, tumor progression, and malignant transformation in patients with WHO grade II gliomas. Materials and methods 1H-MRS and MR imaging (MRI) were performed before surgery in 45 patients with histologically proven WHO grade II gliomas. Metabolite concentrations of choline-containing compounds (Cho) and creatine/phosphocreatine (tCr) were normalized to contralateral brain tissue. Spectroscopic data as well as the extent of tumor resection, contrast enhancement, size and histopatholocical type of the tumor, age, sex, and first neurological symptoms of the patients were analyzed for survival, tumor progression, and malignant transformation for a follow-up period of 1 to 5 years. Results The normalized tCr of WHO grade II gliomas was a significant predictor for tumor progression (p = 0.011) and for malignant tumor transformation (p = 0.016). Further, contrast enhancement of the tumor (p = 0.014) at the time of diagnosis was significant for malignant tumor transformation and extent of tumor resection for the tumor progression (p = 0.007). All other parameters failed to predict any of the three endpoints. Conclusion Normalized values of tCr in WHO grade II gliomas may have prognostic implications for this group of gliomas. As a rule of the thumb, low-grade gliomas with decreased tCr (relative tCr values below 1.0) may show longer progression-free times and later malignant transformation than low-grade gliomas with regular or increased tCr values.Keywords
This publication has 41 references indexed in Scilit:
- Myo‐Inositol: a marker of reactive astrogliosis in glial tumors?NMR in Biomedicine, 2007
- Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancyNeuroradiology, 2006
- Quantitative Short Echo Time 1H-MR Spectroscopy of Untreated Pediatric Brain Tumors: Preoperative Diagnosis and Characterization2006
- Can Tumor Contrast Enhancement Be Used as a Criterion for Differentiating Tumor Grades of Oligodendrogliomas?2005
- Glial Tumor Grading and Outcome Prediction Using Dynamic Spin-Echo MR Susceptibility Mapping Compared with Conventional Contrast-Enhanced MR: Confounding Effect of Elevated rCBV of Oligodendroglimoas2004
- Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliabilityMagnetic Resonance Imaging, 2001
- Relationships Between Choline Magnetic Resonance Spectroscopy, Apparent Diffusion Coefficient and Quantitative Histopathology in Human GliomaJournal of Neuro-Oncology, 2000
- Signal modulation in1H magnetic resonance spectroscopy using contrast agents: Proton relaxivities of choline, creatine, andN-acetylaspartateMagnetic Resonance in Medicine, 1999
- Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy.1996
- The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomasCancer, 1994